Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
Florian Tran, Danielle M M Harris, Alena Scharmacher, Hanna Graßhoff, Kristina Sterner, Susanne Schinke, Nadja Käding, Jens Y. Humrich, Otávio Cabral-Marques, Joana P. Bernardes, Neha Mishra, Thomas Bahmer, Jeanette Franzenburg, Bimba F. Hoyer, Andreas Glück, Martina A. Guggeis, Alexander Ossysek, Andre Küller, Derk Frank, Christoph Lange, Jan Rupp, Jan Heyckendorf, Karoline I. Gaede, Howard Amital, Philip Rosenstiel, Yehuda Shoenfeld, Gilad Halpert, Avi Z. Rosenberg, Kai Schulze‐Forster, Harald Heidecke, Gabriela Riemekasten, Stefan Schreiber
Abstract
https://bit.ly/3pqM9Vv.
Topics & Concepts
MedicineAutoantibodyCoronavirus disease 2019 (COVID-19)PathogenesisProtease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorImmunologyVirologyAllosteric regulationPlateletAntibodyInternal medicineDiseaseEnzymeBiologyBiochemistryInfectious disease (medical specialty)OutbreakBlood Coagulation and Thrombosis MechanismsCOVID-19 Clinical Research StudiesKawasaki Disease and Coronary Complications